SYK

+ Watchlist + Portfolio

Stryker Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $339.98
52-Week Range: $281.00 – $396.86
Market Cap: $125.70B
P/E (TTM): 33.92
EPS (TTM): 9.66
Dividend Yield: 1.04%

Advanced Metrics

Price/Book: 5.24
PEG Ratio: 1.60
Return on Equity: 16.51%
Return on Assets: 8.16%
Gross Margin: 65.59%
Operating Margin: 27.02%
Profit Margin: 14.43%
Current Ratio: 2.16
Debt/Equity: 0.64
Total Debt: $15.45B
Free Cash Flow: $4.11B
Revenue Growth: 9.40%
Earnings Growth: 44.10%
Enterprise Value: $137.67B

SYK Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$18.45B	$20.50B	$22.59B	$25.12B
Cost of Revenue	$6.87B	$7.44B	$8.15B	$9.05B
Gross Profit	$11.58B	$13.06B	$14.44B	$16.07B
Research & Development	$1.45B	$1.39B	$1.47B	$1.62B
Selling, General & Admin	$6.39B	$7.11B	$7.68B	$8.65B
Operating Expenses	$8.47B	$9.13B	$9.77B	$11.01B
Operating Income	$3.11B	$3.92B	$4.67B	$5.06B
EBITDA	$4.11B	$5.06B	$4.95B	$6.31B
Pretax Income	$2.68B	$3.67B	$3.49B	$4.51B
Income Tax	$325.00M	$508.00M	$499.00M	$1.27B
Net Income	$2.36B	$3.17B	$2.99B	$3.25B
Diluted EPS	6.17	8.25	7.76	8.40
Diluted Shares	382.20M	383.70M	385.60M	386.50M

SYK Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.84B	$2.97B	$3.65B	$4.01B
Receivables	$3.56B	$3.77B	$3.99B	$4.04B
Inventory	$4.00B	$4.84B	$4.77B	$5.31B
Current Assets	$10.28B	$12.52B	$14.85B	$14.76B
Total Assets	$36.88B	$39.91B	$42.97B	$47.84B
Current Liabilities	$6.30B	$7.92B	$7.62B	$7.79B
Long-Term Debt	$11.86B	$10.90B	$12.19B	$14.86B
Total Debt	$13.05B	$12.99B	$13.60B	$15.86B
Total Liabilities	$20.27B	$21.32B	$22.34B	$25.42B
Retained Earnings	$14.77B	$16.77B	$18.53B	$20.47B
Shareholders' Equity	$16.62B	$18.59B	$20.63B	$22.42B
Working Capital	$3.97B	$4.60B	$7.23B	$6.96B
Net Debt	$11.20B	$10.02B	$9.95B	$11.85B

SYK Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$2.62B	$3.71B	$4.24B	$5.04B
Capital Expenditure	-$588.00M	-$575.00M	-$755.00M	-$761.00M
Free Cash Flow	$2.04B	$3.14B	$3.49B	$4.28B
Depreciation & Amortisation	$998.00M	$1.03B	$1.05B	$1.19B
Stock-Based Compensation	$168.00M	$205.00M	$229.00M	$243.00M
Investing Cash Flow	-$2.92B	-$962.00M	-$3.00B	-$4.87B
Financing Cash Flow	-$749.00M	-$1.59B	-$525.00M	$113.00M
Dividends Paid	-$1.05B	-$1.14B	-$1.22B	-$1.28B
Net Change in Cash	-$1.05B	$1.16B	$717.00M	$291.00M

SYK Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$6.02B	$6.06B	$7.17B	$6.02B	$6.59B
Cost of Revenue	$2.18B	$2.21B	$2.54B	$2.21B	$2.09B
Gross Profit	$3.84B	$3.85B	$4.63B	$3.81B	$4.50B
Research & Development	$407.00M	$410.00M	$401.00M	$413.00M	$434.00M
Selling, General & Admin	$2.08B	$2.04B	$2.23B	$2.28B	$2.23B
Operating Expenses	$2.67B	$2.64B	$2.82B	$2.87B	$2.84B
Operating Income	$1.17B	$1.21B	$1.81B	$936.00M	$1.66B
EBITDA	$1.47B	$1.52B	$2.19B	$1.30B	$2.00B
Pretax Income	$1.02B	$1.03B	$1.71B	$850.00M	$1.56B
Income Tax	$132.00M	$170.00M	$856.00M	$105.00M	$288.00M
Net Income	$884.00M	$859.00M	$849.00M	$745.00M	$1.28B
Diluted EPS	2.29	2.22	2.20	1.93	3.30
Diluted Shares	386.40M	386.70M	386.50M	386.50M	386.00M

SYK Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$2.38B	$3.26B	$4.01B	$2.88B	$3.39B
Receivables	$3.92B	$3.64B	$4.04B	$3.57B	$3.74B
Inventory	$5.29B	$5.37B	$5.31B	$5.42B	$5.52B
Current Assets	$13.00B	$13.71B	$14.76B	$13.34B	$14.42B
Total Assets	$46.33B	$47.06B	$47.84B	$46.29B	$47.93B
Current Liabilities	$7.29B	$7.41B	$7.79B	$6.32B	$6.68B
Long-Term Debt	$14.83B	$14.85B	$14.86B	$14.22B	$14.19B
Total Debt	$16.58B	$16.59B	$15.86B	$14.72B	$14.94B
Total Liabilities	$25.14B	$25.27B	$25.42B	$23.31B	$23.94B
Retained Earnings	$19.42B	$19.96B	$20.47B	$20.88B	$21.82B
Shareholders' Equity	$21.19B	$21.79B	$22.42B	$22.98B	$23.99B
Working Capital	$5.71B	$6.30B	$6.96B	$7.02B	$7.73B
Net Debt	$14.21B	$13.34B	$11.85B	$11.85B	$11.55B

SYK Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$1.11B	$1.54B	$2.14B	$581.00M	$1.26B
Capital Expenditure	-$183.00M	-$187.00M	-$268.00M	-$166.00M	-$202.00M
Free Cash Flow	$928.00M	$1.35B	$1.88B	$415.00M	$1.06B
Depreciation & Amortisation	$296.00M	$309.00M	$316.00M	$300.00M	$296.00M
Stock-Based Compensation	$49.00M	$62.00M	$48.00M	$87.00M	$54.00M
Investing Cash Flow	-$104.00M	-$321.00M	-$305.00M	-$185.00M	-$639.00M
Financing Cash Flow	-$989.00M	-$339.00M	-$1.09B	-$1.51B	-$95.00M
Dividends Paid	-$321.00M	-$322.00M	-$321.00M	-$337.00M	-$337.00M
Net Change in Cash	$18.00M	$880.00M	$745.00M	-$1.11B	$527.00M

Market Snapshot

About

Stryker Corporation is a leading medical technology company specializing in orthopedics, medical and surgical equipment, and neurotechnology and spine products. The company serves healthcare providers worldwide with innovative solutions for joint replacement, trauma, spine, and surgical equipment. Stryker is known for its strong market position in orthopedic implants and medical devices used in operating rooms and hospitals.